🇺🇸 FDA
Patent

US 8350027

Dual-acting pyrazole antihypertensive agents

granted A61PA61P13/00A61P13/12

Quick answer

US patent 8350027 (Dual-acting pyrazole antihypertensive agents) held by Theravance, Inc. expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Jan 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61P, A61P13/00, A61P13/12, A61P29/00, A61P3/06